Contents

Current Cancer Drug Targets, Volume 13 - Number 8

In Memory of Dr. Herbert E. Nieburgs – Ex-Associate Editor of CCDT

, 13(8): 811 - 813


DOI: 10.2174/1568009611313080001




Small Molecule Inhibitors of Multidrug Resistance Gene (MDR1) Expression: Preclinical Evaluation and Mechanisms of Action

, 13(8): 814 - 828

Sofia A. Santos and Alexandra Paulo


DOI: 10.2174/15680096113139990082




Protein Phosphatase 2A as a Potential Target for Treatment of Adult T Cell Leukemia

, 13(8): 829 - 842

Naoki Mori, Chie Ishikawa, Jun-Nosuke Uchihara and Takeshi Yasumoto


DOI: 10.2174/156800961131300093




Signal Transduction in Human Cutaneous Melanoma and Target Drugs

, 13(8): 843 - 866

Anatoly B. Uzdensky, Svetlana V. Demyanenko and Mikhail Y. Bibov


DOI: 10.2174/1568009611313080004




β-Catenin Knockdown in Liver Tumor Cells by a Cell Permeable Gamma Guanidine-based Peptide Nucleic Acid

, 13(8): 867 - 878

Evan Delgado, Raman Bahal, Jing Yang, Jung M. Lee, Danith H Ly and Satdarshan P. S. Monga


DOI: 10.2174/15680096113139990081




Ipilimumab and Vemurafenib: Two Different Routes for Targeting Melanoma

, 13(8): 879 - 894

Ana Burgeiro, Faustino Mollinedo and Paulo J. Oliveira


DOI: 10.2174/15680096113139990080




Significance of Prion and Prion-Like Proteins in Cancer Development, Progression and Multi-Drug Resistance

, 13(8): 895 - 904

Caroline Hinton, Helma Antony, Saeed M. Hashimi, Alan Munn and Ming Q. Wei


DOI: 10.2174/156800961131300092




Webmaster Contact: info@benthamscience.org
Copyright © 2018 Bentham Science